Equities

Allergy Therapeutics PLC

Allergy Therapeutics PLC

Actions
  • Price (EUR)0.053
  • Today's Change-0.004 / -6.19%
  • Shares traded10.00k
  • 1 Year change+165.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments131521
Total Receivables, Net7.825.065.91
Total Inventory131211
Prepaid expenses--2.034.56
Other current assets, total------
Total current assets333442
Property, plant & equipment, net242320
Goodwill, net3.323.353.35
Intangibles, net1.371.791.69
Long term investments2.914.875.33
Note receivable - long term------
Other long term assets------
Total assets656773
LIABILITIES
Accounts payable--4.094.28
Accrued expenses--1211
Notes payable/short-term debt--00
Current portion long-term debt/capital leases2.121.802.27
Other current liabilities, total2.490.180.16
Total current liabilities211918
Total long term debt29348.26
Total debt313611
Deferred income tax0.380.450.41
Minority interest------
Other liabilities, total11118.46
Total liabilities616535
SHAREHOLDERS EQUITY
Common stock4.780.690.65
Additional paid-in capital155119113
Retained earnings (accumulated deficit)(157)(118)(76)
Treasury stock - common------
Unrealized gain (loss)1.781.501.07
Other equity, total(0.82)(0.73)(0.92)
Total equity3.712.0738
Total liabilities & shareholders' equity656773
Total common shares outstanding4,7761,7171,717
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.